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Human S100A2 is an EF-hand calcium-binding S100 protein that is localized mainly in the nucleus and functions as tumor suppressor. In
addition to Ca2+ S100A2 binds Zn2+ with a high affinity. Studies have been carried out to investigate whether Zn2+ acts as a regulatory ion for
S100A2, as in the case of Ca2+. Using the method of competition with the Zn2+ chelator 4-(2-pyridylazo)-resorcinol, an apparent Kd of 25 nM has
been determined for Zn2+ binding to S100A2. The affinity lies close to the range of intracellular free Zn2+ concentrations, suggesting that S100A2
is able to bind Zn2+ in the nucleus. Two Zn2+-binding sites have been identified using site directed mutagenesis and several spectroscopic
techniques with Cd2+ and Co2+ as probes. In site 1 Zn2+ is bound by Cys21 and most likely by His 17. The binding of Zn2+ in site 2 induces the
formation of a tetramer, whereby the Zn2+ is coordinated by Cys2 from each subunit. Remarkably, only binding of Zn2+ to site 2 substantially
weakens the affinity of S100A2 for Ca2+. Analysis of the individual Ca2+-binding constants revealed that the Ca2+ affinity of one EF-hand is
decreased about 3-fold, whereas the other EF-hand exhibits a 300-fold decrease in affinity. These findings imply that S100A2 is regulated by both
Zn2+ and Ca2+, and suggest that Zn2+ might deactivate S100A2 by inhibiting response to intracellular Ca2+ signals.
© 2006 Elsevier B.V. All rights reserved.Keywords: S100; S100A2; Zinc; Calcium; Cobalt1. Introduction
S100 proteins are small acidic EF-hand calcium-binding
proteins comprised of a modified, S100-specific EF-hand at the
N-terminus and a classical C-terminal EF-hand [1]. All S100
proteins, with the exception of the evolutionarily distinct
S100G, form homo- and hetero-dimers. These proteins show
remarkable cell- and tissue-specific expression patterns, and are
involved in widely different processes including cell cycle
regulation, cell growth, differentiation and motility. Dysregula-
tion of specific S100 proteins is associated with a variety ofAbbreviations: ANS, 4,4′-dianilino-1,1′-binaphtyl-5,5′-sulfonic acid; PAR,
4-(2-pyridylazo)-resorcinol
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doi:10.1016/j.bbamcr.2006.12.006human diseases, including cancer, and neurodegenerative and
cardiovascular disorders [2].
Human S100A2 is unique among the S100 proteins because
it is predominantly localized in the nucleus [3]. S100A2 was
identified as a tumor suppressor in human mammary epithelial
cells, and downregulation of the protein was observed in tumor
tissues of prostate adenocarcinoma, lung cancer and breast
carcinoma [4]. Recent studies show that S100A2 binds and
activates p53, in a Ca2+-dependent manner [5]. This finding
directly links the tumor suppressing activities of S100A2 and
p53 and suggests a positive regulation of p53 through S100A2.
So far only the biochemical and regulatory properties of human
S100A2, but not from orthologs of other mammals, have been
studied to some extent. S100A2 orthologs are reported in
chimpanzee (GenBank accession No. XP_513815), dog
(GenBank accession No. XP_855158) and cow (GenBank
accession No. NM_001034367). The protein from chimpanzee
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whereas the orthologs from dog and cow contain only one Cys
residue at position 86.
Multi-dimensional NMR studies on S100A2 revealed a
molecular architecture similar to that described for other S100
proteins [6]. Each subunit of S100A2 is comprised of four α-
helices, [residues 7–21 (helix I), 31–40 (helix II), 52–64 (helix
III), and 72–95 (helix IV)] organized into two EF-hands. The
protein exhibits an affinity for Ca2+ comparable to other S100
proteins, however, it is reported that it binds Zn2+ with high
affinity [7,8]. Each S100A2 subunit carries four cysteine
residues (Cys2, Cys21, Cys86, Cys93) (Fig. 1) that are
presumably involved in the coordination of Zn2+. The Zn2+-
binding sites of S100A2 have been subject of three investiga-
tions, with virtually no consensus as to stoichiometry, affinity,
location, and structure. Franz et al. [8] proposed two potential
binding motifs including His17–Cys21–His39 and Cys2–
Cys86–Cys93, whereas Stradal et al. [7] suggested that two
binding sites consist of Cys2–His39 and of His17–Cys86–
Cys93. In a study by Randazzo et al. [6], it was concluded that
one site is formed by residues His17–Cys21–Cys93 and
another by Cys2–His39, with Cys86 participating in either
the first or the second binding site. None of these studies
included direct measurements of the affinity and stoichiometry
of Zn2+ bound per S100A2, nor was the possible function of
Zn2+ binding to S100A2 discussed.
There is emerging evidence for the role of Zn2+ as a key
regulatory ion in cellular processes [9]. The total Zn2+
concentration in eukaryotic cells is on the order of several
hundred μM [10], but the majority of intracellular Zn2+ is bound
to zinc finger proteins [11], metallothioneins [12], and reduced
glutathione [13]. The residual free Zn2+ concentration is rather
low and ranges from pM to nM levels. The concentration of free
Zn2+ varies in different cell types and changes rapidly upon
cellular stimulation. In resting human monocytes and lympho-
cytes the free Zn2+ concentration ranges between 0.17 and
0.35 nM [14]. Similar basal levels are reported for chromaffin
cells where the free Zn2+ concentration rises from 0.4 to 2 nM
upon electrical stimulation [15]. In neurons, the changes in free
Zn2+ are much more pronounced and show larger amplitudes.Fig. 1. Location of cysteine residues in a S100A2 subunit. Schematic view a
S100A2 subunit based on the structural information by Randazzo et al. [6]. The
locations of the four cysteine residues are indicated. Cys2 resides at the N-
terminus of helix I, Cys21 in the N-terminal EF-hand, Cys86 at the C-terminus
of helix IV, and Cys93 in the unstructured C-terminal region.Dependent on the type of stimulation and on the extracellular
Zn2+ concentrations, the free Zn2+ levels reach 35–45 nM [16]
or even 250–300 nM [17] in cultured neocortical neurons.
Within signaling microdomains the transient free Zn2+
concentrations have been reported to rise up to 10 μM [18].
The large number of Zn2+-dependent DNA binding and
regulatory proteins suggests that changes in free Zn2+ are
directly translated into altered gene expression [19]. However,
there is also an immediate cellular response to elevated Zn2+
levels, which activate or inhibit several key enzymes from
different signaling cascades [20,21]. Intracellular information
transfer by Zn2+ binding to proteins, in a manner analogous to
Ca2+, was first discussed nearly a decade ago [22]. Interestingly,
Zn2+ binding to other S100 proteins like S100B or S100A12
increases their affinity for Ca2+ affinity [23,24] and directly
links Zn2+ and Ca2+ signaling in the cell.
The potential importance of S100A2 as a nuclear protein
linked to p53 prompted studies to determine whether S100A2
binds Zn2+ at such low intracellular concentrations and whether
Zn2+ binding has an effect on the Ca2+-binding properties of
S100A2. First, the affinity of S100A2 for Zn2+ was quantified.
Using site-directed mutagenesis, metal ion-binding studies,
spectroscopic methods, and molecular modeling, we demon-
strated the existence of two different Zn2+-binding sites. Zn2+
binding to site 1 had only minor effects on the protein structure.
In contrast, binding of Zn2+ in site 2 caused a 300-fold decrease
in Ca2+ affinity in one EF-hand and the formation of a
tetrameric state that has not been observed previously. These
results provide a critical foundation for understanding the
functional role of Zn2+ binding in S100A2.
2. Material and methods
4-(2-pyridylazo)-resorcinol (PAR), 4,4′-dianilino-1,1′-binaphtyl-5,5′-sulfo-
nic acid (bis-ANS), and 2,2′-dithiopyridine were purchased from Fluka. All
other reagents were of the highest commercially available grade and were used
without further purification.
2.1. Protein expression and purification
Human S100A2 was sub-cloned into the bacterial expression vector
pMW172 and cysteine deficient variants were generated by site-directed
mutagenesis, as described elsewhere [7]. E. coli BL21(DE3) clones expressing
the proteins were grown in DYT medium containing 0.2% glucose and
100 μg/ml ampicillin at 310 K. At OD600≈0.6, 0.5 mM IPTG was added to
induce expression. After 3 h the cells were harvested by centrifugation
(6,000 g, 20 min) and cell pellets were frozen in liquid nitrogen and stored at
200 K.
To purify the proteins, 10–15 g cells were suspended in 40 ml of 50 mM
Tris–HCl (pH 7.6), the solutions were brought to 0.5 mM MgCl2 and 0.4% of
PMSF, and a few crystals of DNAse I were added. Cell contents were released
by two passages through a French Press at 138 MPa. Then 1 mM EDTA and
5 mM DTT were added and the crude extract was centrifuged at 100,000 g for
1 h. 5 mM CaCl2 was added to the supernatant and loaded onto phenylsepharose
column (3.5×10 cm, GE Healthcare) equilibrated with 50 mM Tris–HCl, 5 mM
CaCl2, pH 7.6. The column was washed with 1.5 l of the same buffer and
S100A2 was eluted with 50 mM Tris–HCl, 10 mM EDTA, pH 7.6. The eluate
was concentrated by ultrafiltration (10 kDa, Amicon) and loaded onto a
Superdex 75 (2.6×60 cm, GE Healthcare) column equilibrated with 20 mM
Tris–HCl, 150 mM NaCl, pH 7.6. Fractions containing S100A2 were combined
and concentrated to 10 mg/ml, then stored at 200 K. Purity was controlled by
SDS-Page and UV spectra. Protein concentration was calculated using the
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quantitative amino acid analysis.
Prior to all experiments the proteins were incubated with a 300-fold excess
of DTT for 2 h at 310 K to reduce all cysteine residues. Metal ions were removed
by addition of 0.5 mM EDTA; both EDTA and DTT were removed on a NAP5
desalting column (GE Healthcare) equilibrated with the chosen buffer.
Human recombinant S100B, which served as a control in several
experiments, was prepared as described elsewhere [25].
2.2. Determination of sulfhydryl groups
SH groups were determined with 2,2′-dithiopyridine. Aliquots of the
S100A2 variants were added to 6 M Gu–HCl, 10 mM EDTA, 50 mM Tris–HCl,
pH 8.3. After mixing, 50 μl of 3.2 mM 2,2′-dithiopyridine in 0.2 M Na–acetate
(pH 4.0) was added and the absorption at 343 nm was recorded (ε343 nm=7,600
M−1 cm−1) [26].
2.3. Size exclusion chromatography
A Superdex 75 HR (1.0×30 cm, GE Healthcare) column was calibrated with
proteins of known molecular mass. The Zn2+-dependent oligomerisation of the
S100A2 proteins was monitored in 20 mM Tris–HCl, 150 mM NaCl, pH 7.6
containing either 100 μM or 1 mM ZnCl2 as running buffers. The concentration
of the injected protein was 90 μM (homodimer). MgCl2 was added up to 10 mM
to prevent non-specific Zn2+ binding to the surface of S100A2.
2.4. Mass spectrometry
Mass spectra were obtained on a PE SCIEX API 365 LC/MS/MS
electrospray ionization mass spectrometer (Perkin Elmer). Samples were
dialyzed against water and diluted to a final concentration of 50 μg/ml in
running medium containing 50% acetonitrile and 0.1% acetic acid or 3 mM
ammonium acetate; 20 μl were injected per run.
2.5. Dynamic light scattering
DLS experiments were carried out at 4 °C in the absence or presence of one
equivalent of ZnCl2, in quartz micro-cells (1.0 cm) on a DynaPro-MS/X system.
Data were analyzed with the program Dynamics (Proterion Corporation).
The concentration of ZnCl2 stock solutions was determined by flame atomic
absorption spectrometry (SpectrAA-110, Varian Inc.). The Zn2+ content of
protein fractions from size exclusion chromatography was determined according
to [27] and corrected for the Zn2+ concentration of the buffer.
2.6. Determination of Zn2+ dissociation constants
The procedure is based on the competition of 4-(2-pyridylazo)-resorcinol
(ZnPAR2, Kd=3.0×10
−13, 20 mM HEPES–NaOH, pH 7.4) and S100A2 for
Zn2+ [28]. The protein concentration was 2 μM with PAR at 10 μM in 20 mM
HEPES–NaOH, 5 mM MgCl2, pH 7.4. Zn
2+ was added in 0.5 μM steps. For
determinations of Zn2+ affinity constants in the presence of Ca2+, 2 mM CaCl2
was added. The assay was carried out at 298 K. It was assumed that the excess of
PAR is high enough to form completely a Zn2+–PAR2 complex. The dissociation
constant of Zn2+–PAR2 was determined photometrically at 494 nm (Eq. 1). The
absorption of the Zn2+–PAR2 complex was measured at different Zn
2+
concentrations and the dissociation constants of the Zn2+–S100A2 complexes
(Eq. 2) were calculated according to Eq. 3.
Kd ZnPAR2ð Þ ¼ ½Znfreed½PARfree
2
½ZnPAR2 ð1Þ
Kd ZnS100A2ð Þ ¼ ½Znfreed½S100A2free½ZnS100A2 ð2Þ
Kd ZnS100A2ð Þ ¼ KdðZnPAR2Þd½ZnPAR2d½S100A2free½PARfree2d½ZnS100A2
ð3Þwith [ZnS100A2]=[Zn2+tot]−[ZnPar2], [S100A2free]=[S100A2tot]−[ZnS100A2],
and [PARfree]=[PARtot]−2[ZnPar2]. [S100A2]tot=total concentration of zinc
binding sites present in the assay.
2.7. Determination of Ca2+ dissociation constants
The Ca2+-binding constants of S100A2 were determined by Ca2+ titrations
in the presence of the fluorophore chelator BAPTA-5N (Invitrogen) in 10 mM
MOPS, 100 mM KCl pH 7.2. The protein concentration was 10 or 20 μM and
BAPTA-5N was added to a final concentration of 5 μM. The fluorescence signal
of BAPTA-5N was recorded at 522 nm upon excitation at 492 nm and was
followed as a function of total Ca2+ concentration. The titration curve was
analyzed using the program CaLigator [29]. The resulting fits were exported and
plotted with the program Origin (OriginLab). BAPTA-based Ca2+ indicators are
highly selective for Ca2+ over Mg2+, however they bind other divalent cations
such as Zn2+ with much higher affinity. Therefore we assessed the Ca2+ affinity
in the presence of Zn2+ by the Ca2+-dependent change of intrinsic tyrosine
fluorescence. The protein concentration in tyrosine fluorescence monitored
experiments was 10 μM in 20 mM Tris–HCl, 5 mM MgCl2, pH 7.6. All
emission spectra were recorded with a Perkin Elmer LS50B instrument equipped
with a thermostatted cell holder at 298 K. Ca2+ was titrated to metal-free or to
Zn2+-loaded protein until saturation was reached.
2.8. UV/Vis, circular dichroism (CD), and magnetic circular dichroism (MCD)
Solutions of buffers and metal ions (Ca2+, Co2+, Zn2+, Cd2+) were prepared
with Chelex 100 (Biorad) treated water throughout. Prior to adjustment of pH,
the Chelex 100 resin was added (0.5 g/100 ml) and the solution was stirred for
1 h. After adjustment of pH, the solution was passed through a 0.2 μm filter and
stored in metal-free plastic vials. All experiments with Co2+ were carried out
under exclusion of dioxygen. Dioxygen was removed by 8–10 cycles of vacuum
and flushing with argon 5.0; all solutions were stored in a Coy anaerobe chamber
(95% N2/5% H2) with dioxygen levels below 0.1 ppm.
UV/Vis spectra in the range 280–800 nm were recorded with a Perkin-Elmer
Lambda 16 spectrophotometer in 0.1 and 1.0 cm quartz cells. In the case of Zn2+
and Cd2+, protein was 30 μM in 20 mM Tris–HCl, 5 mM MgCl2, pH 7.6; for
Co2+, protein was 300 μM in 20 mM Tris–HCl, 5 mM MgCl2, pH 8.3. The
absorbance was corrected for dilution.
CD and MCD spectra of Co2+ complexes were recorded on a Jasco J-810
instrument at a magnetic field of 1.5 T; the differences in extinction ε were
calculated according to Nakanishi et al. [30]. UV CD spectra were recorded as
described above in 20 mM Tris–HCl, 5 mM MgCl2, pH 7.6, in 0.10 cm and
0.01 cm quartz cells between 180 and 260 nm. The α-helical content was
calculated with CDNN 2.1 [31].
2.9. EPR spectroscopy
EPR spectra of Co2+-S100A2 variants in 20 mM Tris–HCl, 5 mM MgCl2,
pH 8.3 were recorded on a Bruker Elexsys 500 instrument. Typical experimental
conditions were 0.5 mT modulation amplitude, 20 mW microwave power, 9.38
GHz (X-band), and 10 K (ITC 503 temperature control, Oxford Instruments).
2.10. NMR experiments
U-13C,15N labelled S100A2-WTwas expressed in E. coli grown in minimal
media containing 13C6-glucose and
15NH4Cl as the sole carbon and nitrogen
sources, then purified as described previously [6]. The purified apo-protein was
exchanged into a NMR buffer containing 20 mMTris–HCl, 90% H2O/10%D2O
at pH 8.0. The buffer was treated with Chelex beads to remove trace metal ions
and the dissolved oxygen was removed by bubbling argon through the solution
before exchanging the protein into the NMR buffer using NAP5 columns (GE
Healthcare). The final protein concentration after the buffer change was
determined to be 105 μM, i.e. 52 μM homodimer. Only 0.9 equivalents of Zn2+
were added in order to fill only Zn2+-binding site 1 of S100A2. In order to
prevent oxidation of the cysteines of S100A2 in the NMR sample (650 μl) the
headspace of the NMR tube was purged with argon for 10 min and then sealed
gastight. 15N–1H HSQC spectra were acquired on a 600 MHz Bruker AVANCE
spectrometer at 300 K.
Fig. 2. CD-spectra of S100A2-WT and comparison with S100A2-C2S. Solid
line: metal free S100A2, dotted line: Ca2+-loaded S100A2, dashed line: Zn2+-
loaded S100A2. (A) CD-spectra of metal free and Ca2+- and Zn2+- loaded
S100A2-WT. (B) Comparison of changes in CD upon Zn2+ and Ca2+ binding
to S100A2-WT and S100A2-C2S. The protein concentration was 163 μM
with 163 μM Zn2+ or with 1.6 mM Ca2+ respectively in 20 mM Tris–HCl,
pH 7.6.
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The crystal structures of apo S100A3 (1KSO) [32], apo S100A6 (1K9P), and
Ca2+-loaded S100A6 (1K96) [33] served as templates. Modeling was carried out
with the programs Modeller [34] and O [35].
3. Results
3.1. Selection and characterization of S100A2 variants
In the previous studies of Zn2+ binding to S100A2 it was
proposed that cysteine residues play a crucial role. However, it
was unclear which of the four cysteine residues (Cys2, Cys21,
Cys86, Cys93) per subunit are involved in Zn2+ binding. The
schematic representation of the two EF-hands within a S100A2
subunit (Fig. 1) shows the location of the 4 cysteine residues.
Assuming that one Cys→Ser mutation is sufficient to perturb
a Zn2+-binding site effectively, we analyzed the four single
mutants. In order to examine the possibility of multiple cysteine-
containing zinc sites, two additional S100A2 variants carrying
triple Cys→Ser mutations were analyzed.
Wild-type S100A2 and the cysteine variants were expressed
and purified to homogeneity. The mutations and the correct
size of the proteins were confirmed by mass spectrometry and
cysteine analysis (Supplement Table I). Several cysteine
residues in S100A2 appeared susceptible to air oxidation as
observed previously [7]. Consequently, all manipulations of
samples were performed in an atmosphere of 95% N2 and 5%
H2 to prevent formation of intermolecular or intramolecular
disulfide bonds. According to size exclusion chromatography,
all of the apo-proteins were homodimers with an apparent
mass of about 20 kDa as described for other S100 proteins
[4].
The S100A2 variants were examined by CD spectroscopy
for possible structural changes induced by the Cys→Ser
mutations. The spectra of all variants were closely similar to
the spectrum of S100A2-WT. Thus, it is reasonable to assume
that the proteins fold to the same structure. Analysis of the
secondary structure elements using the program CDNN
revealed a content of about 50–55% α-helix for S100A2-
WT and all mutants, in good agreement with previous NMR
analysis of S100A2 [6]. Moreover, S100A2-WT and all
S100A2 variants showed an increase of α-helical content
upon the addition of Ca2+ (60–65% α-helix), confirming that
the Ca2+-induced conformational change occurs in all of the
variants.
3.2. Structural characterization of Zn2+-bound S100A2
Zn2+ binding to S100A2-WT caused a small but
reproducible decrease in the α-helical content of about 3–
4% (Fig. 2A, B) as shown by CD spectroscopy. This small
conformational change upon Zn2+ binding was slightly more
pronounced in S100A2-C21S with a decrease of 7% (not
shown), but was virtually absent in S100A2-C2S where a
decrease of only 0.5–1% was observed (Fig. 2B). Since Zn2+
binds via cysteine residues to S100A2 CysS→Zn2+ LMCT
can overlay the CD signal from the protein backbone andmake the exact quantification of the structural changes
difficult.
The influence of Zn2+ on the degree of oligomerization of
S100A2 and the variants was analyzed by size exclusion
chromatography (SEC) and dynamic light scattering. In the
absence of Zn2+ S100A2-WT and variants eluted from SEC at a
volume corresponding to the homodimeric protein. Neither
Ca2+ nor Mg2+ induced major changes in this behavior (data not
shown) and no oxidation of Cys residues was observed during
the run. However, Zn2+-loaded S100A2-WT and variants which
still contain Cys2 eluted at higher apparent molecular mass
corresponding to a tetramer (∼46 kDa) (Fig. 3). The Zn2+-
induced S100A2 tetramer was also observed in the presence of
physiological concentrations of Mg2+ (0.5 mM). Increasing the
Mg2+ concentration up to 10 mM did not affect the tetramer
formation, showing that the interaction is Zn2+ specific.
S100A2 variants S100A2–C2S and S100A2–C2S–C86S–
C93S lacking Cys2 did not form a tetramer in the presence of
Fig. 4. Binding of Ca2+ to S100A2-WTand S100A2-C2S monitored by tyrosine
fluorescence. Protein concentration is 10 μM in 20 mMTris–HCl, 5 mMMgCl2,
pH 7.6. (A) binding of Ca2+ to S100A2-WT; (B) binding of Ca2+ to S100A2–
C2S in the absence (▪) and presence of 15 μMZn2+ (▴). Ca2+-binding constants
are given in Table 2.
Fig. 3. Zn2+-dependent oligomerization of S100A2-WT and variants monitored
by size exclusion chromatography. Superdex 75 HR (1.0×30 cm) column,
20 mM Tris–HCl, pH 7.6, 300 μg protein per run. (A) S100A2-WT, (B)
S100A2–C2S, (C) S100A2–C21S, (D) S100A2–C86S, (E) S100A2–C94S,
(F) S100A2–C2S–C86S–C93S, and (G) S100A2–C21S–C86S–C93S without
Zn2+ (solid line) and with 100 μM Zn2+ (line and circle). For S100A2–C21S–
C86S–C93S 1 mM Zn2+ was used.
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recombinant S100B, which also binds Zn2+ with high affinity
[36] served as a control and did not form larger aggregates in
SEC experiments under the same conditions. The formation of
the tetrameric species of S100A2-WT upon Zn2+ binding was
confirmed by dynamic light scattering. As in the size exclusion
experiments, S100A2–C2S showed no Zn2+-induced oligomer-
ization and remained dimeric. Thus, only Cys2 is the critical
residue responsible for Zn2+-induced S100A2 tetramer
formation.
As shown previously [8] by fluorescence experiments using
bis-ANS, Ca2+ and Zn2+ binding to S100A2 induces the
exposure of a hydrophobic patch at he surface of the protein. In
order to map the Zn2+-binding site that triggers the increase in
hydrophobic surface we examined Zn2+ dependent bis-ANS
binding to S100A2-WT, S100A2–C2S and S100A2–C21S.
Whereas S100A2–C21S (site 1 defect, vide infra) showed
increased bis-ANS fluorescence like S100A2-WT, S100A2–
C2S (site 2 defect, vide infra) exhibited almost no increase in
bis-ANS fluorescence (Supplement Figure III). The results
indicate that binding of Zn2+ to site 2 but not to site 1 causes
the exposure of hydrophobic residues. These data are
consistent with an apparent conformational change upon
binding of Zn2+ to site 2 as monitored by CD spectroscopy
(Fig. 2).3.3. Affinity of S100A2 for zinc
In order to place the binding of Zn2+ in an appropriate
functional context, the affinity of S100A2 for Zn2+ was
determined using the competitive chelator PAR (Supplement
Figure IV). Other chromogenic or fluorogenic Zn2+ chelators
such as Zincon or Fluo-Zin3 had been tested but were not suited
to determine Zn2+-binding constants of Ca2+-loaded S100A2
because of unspecific interactions of the dyes with the Ca2+-
loaded protein. Non-specific Zn2+ binding most likely to
negatively charged surface residues of S100A2 was observed in
initial experiments. These effects were abrogated by the
addition of Mg2+, which is present in high concentrations in
the cytoplasm, to the solutions. Addition of potassium or
sodium salt at the same concentrations did not affect the Zn2+
binding. In order to obtain correct affinities, the stoichiometry
of Zn2+ per S100A2 has to be known. From initial titrations
using Zn2+, Cd2+, or Co2+ a stoichiometry of about 2.5 Zn2+ per
S100A2 homodimer was determined. Size exclusion experi-
ments revealed the formation of a tetrameric S100A2 species
bridged by Zn2+. Zn2+ and Cd2+ titrations (vide infra) revealed
the resulting S100A2 tetramer contains most likely 5 Zn2+ per
S100A2 tetramer. This value was confirmed by quantitative
analysis of the Zn2+ content of fractions from size exclusion
chromatography containing tetrameric S100A2. The analysis
showed that tetrameric S100A2 contained 1.31±0.01 Zn2+ per
subunit, i.e. 5.2 Zn2+ per tetramer. This further dimer–tetramer
equilibrium could not be modeled with the present data and
made it impossible to extract individual Zn2+-binding constants
in S100A2 from the titrations.Therefore in the fits of the Zn2+-
binding data we assumed a stoichiometry of 2.5 Zn2+ ions per
Table 1
Apparent dissociation constants of Zn2+– and Co2+–S100A2 complexes
Protein Kd Zn
2+–
S100A2
[nM] a
Kd Zn
2+/
Ca2+–S100A2
[nM] b
Kd Co
2+–
S100A2
[μM] c
S100A2-WT 25±6 (10) 49±8 (9) 46±1
S100A2–C2S 42±6 (7) 215±30 (7) 49±1
S100A2–C21S 215±70 (9) 600±190 (5) 700±180
S100A2–C86S 22±6 (9) 42±6 (7) 45±8
S100A2–C93S 64±6 (5) 142±30 (5) 470±210
S100A2–C2S–
C86S–C93S
245±5 (4) no binding ⁎ 510±60
S100A2–C21S–
C86S–C93S
225±150 (4) no binding ⁎ 540±190
a Determined with PAR; affinity of apo-S100A2 and Ca2+-loaded S100A2 for
Zn2+.
b Number of determinations.
c Calculated from UV/Vis titrations.
⁎ The affinity was too low to be determined with PAR.
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S100A2-WT and all variants except those that carry a
Cys2→Ser2 mutation and do not form the Zn2+ dependent
tetramer. For these mutants we assumed a stoichiometry of 2
Zn2+ ions per S100A2 homodimer.
S100A2-WT binds Zn2+ with an apparent Kd=25±6 nM
(Table 1). This affinity is about 100-fold higher than previously
reported by Franz et al. [8]. The lower affinities reported
previously might be due to the fast oxidation of Cys residues in
S100A2. In order to determine how different Cys residues
contributed to Zn2+ binding, the affinity of several Cys→Ser
point mutations were determined. Many mutations resulted in
decreased affinity for Zn2+. However, none of them abolished
Zn2+ binding completely (Table 1). A significant effect was
observed for S100A2–C21S (Kd=215 nM) and the variants
carrying multiple mutations that include C2S, e.g. S100A2–
C2S–C86S–C93A (Kd=245 nM). In contrast, S100A2–C86S
or S100A2–C93S showed no (Kd=22 nM) or a modest decrease
(Kd=64 nM) in Zn
2+ affinity implying that these residues are
not strongly involved in Zn2+ coordination. The observed slight
reduction in Zn2+ affinity of S100A2–C93S was attributed to an
allosteric structural effect.Table 2
Ca2+-binding constants of S100A2 determined by competition with BAPTA-5N or
BAPTA-5N
log affinity/M−1 a
BAPTA-5N
log affinity/M
S100A2-WT K1=3.45±0.07 K1=4.2±0.1
K2=4.06±0.12 K2=3.7±0.6
K3=3.7±0.8
K4=4.7±0.7
S100A2–C2S n.d. n.d.
S100A2–C21S n.d. n.d.
a Fitting 2 identical sets of 2 Ca2+-binding affinities.
b Fitting 4 different Ca2+-binding affinities.
c In the presence of Zn2+.Remarkably, the effects of the Cys→Ser point mutations
were much more pronounced for binding of Zn2+ to Ca2+-
loaded S100A2. While pre-loading with Ca2+ decreased the
Zn2+ affinity of the wild-type protein about 2-fold, Ca2+–
S100A2–C21S exhibited a Kd (Zn
2+) of 600 nM, i.e. a 12-fold
weaker affinity than Ca2+–S100A2–WT. Similarly, Ca2+–
S100A2–C2S exhibited a 4-fold lower affinity for Zn2+ than
Ca2+–S100A2–WT. For Ca2+-loaded S100A2–C2S–C86S–
C93S and S100A2–C21S–C86S–C93S mutants, the affinity
for Zn2+ was too low to be measured by the Zn2+ chelator
method with PAR. In summary, the two mutations Cys2 and
Cys21 had the largest effect on Zn2+ affinity. The distance of
the two Cys residues in the structure of S100A2 (see Fig. 1)
makes it unlikely that both residues are involved in a single
binding site. Therefore, we concluded that two distinct Zn2+ sites
exist: site 1 which employs Cys21 as Zn2+ ligand, and site 2 with
Cys2 as ligand. Moreover, since the Zn2+ affinity towards
S100A2 was altered when Ca2+ was bound, one can conclude
that Ca2+ and Zn2+ binding to S100A2 are not two independent
but rather energetically coupled processes.
3.4. Decrease of calcium affinity by zinc binding
The interplay between Ca2+ and Zn2+ in S100A2 was further
characterized by measurements of the Ca2+ affinity of S100A2
in the presence and absence of Zn2+. The binding of Ca2+ was
followed by intrinsic tyrosine fluorescence as demonstrated
previously [7]. The method was validated by titrations using
BAPTA-5N as competitive fluorophore chelator (Table 2). Apo
S100A2-WT displayed affinity constants of log K1=3.61±0.24
M−1 and log K2=4.22±0.26 M
−1. However, pre-loading the
Zn2+ sites resulted in a dramatic drop (∼300-fold) in Ca2+
affinity of one EF-hand and a smaller drop (∼3-fold) in affinity
of the second EF-hand. The Ca2+-binding constants for Zn2+
loaded S100A2-WT are log K1=3.08±0.12 M
−1 and log
K2=1.76±0.49 M
−1 (Fig. 4, Table 2). The strong decrease in
Ca2+-affinity of S100A2 upon Zn2+ binding was rather
unexpected since Zn2+ binding to other S100 proteins like
S100B or S100A12 increases Ca2+-affinity [23,24]. Since the
intracellular Ca2+ concentration does not reach sufficiently high
levels to bind to Ca2+ sites with such low affinity, these resultsintrinsic change in tyrosine fluorescence
−1 b
Tyr fluorescence
log affinity/M−1 a
Tyr fluorescence
log affinity/M−1 a, c
K1=3.61±0.24 K1=3.08±0.12
K2=4.22±0.26 K2=1.76±0.49
K1=3.56±0.15 K1=3.47±0.08
K2=4.26±0.17 K2=3.73±0.09
K1=3.35±0.21 K1=3.34±0.16
K2=4.50±0.17 K2=1.43±0.18
Fig. 5. Binding of Zn2+ to S100A2-WT monitored by UV difference spectro-
scopy. (A) Difference spectra of Zn2+ loaded S100A2-WT minus apo S100A2-
WT. Protein concentration is 30 μM in 20 mM Tris–HCl, 5 mMMgCl2, pH 7.6.
Spectra for Zn2+ in the range 6–72 μM are shown. The extinction coefficient is
calculated per S100A2 subunit. (B) Course of titration as monitored at 208 nm.
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In order to map the Zn2+-binding site that abolishes Ca2+
binding, the Ca2+ affinities of S100A2–C2S and S100A2–C21S
in the absence and presence of Zn2+ were determined. In the
absence of Zn2+, both S100A2 variants displayed similar Ca2+
affinities like S100A2-WT (Table 2). Upon addition of Zn2+ to
S100A2–C21S, which lacks the essential Cys21 residue of the
designated Zn2+ site 1, the Ca2+ affinity decreased considerably
(Table 2) like in S100A2-WT, i.e. Ca2+-binding affinity is
decreased regardless of the status of Zn2+ binding site 1. In
contrast, mutation of Cys2 in S100A2–C2S almost restored the
Ca2+ affinity in the presence of Zn2+ (Fig. 4B). S100A2–C2S
still contains site 1 but lacks the essential Cys2 of site 2, i.e. a
large decrease in Ca2+ affinity occurs only upon Zn2+ binding to
site 2. These results suggest Zn2+ binding might render S100A2
inactive as Ca2+ sensor.
3.5. Stoichiometry of zinc binding
Fractions from size exclusion chromatography containing
Zn2+-bridged S100A2 were analyzed for the Zn2+ content. The
fractions containing tetramer exhibited a content of 1.3 Zn2+ per
S100A2 subunit, i.e. 5.2 Zn2+ per tetramer. Protein fractions
eluting at higher volume corresponding to a smaller molecular
mass had a Zn2+ content of 0.9 Zn2+ per S100A2 subunit. In
addition we assessed the Zn2+ stoichiometry in UV monitored
Zn2+ titrations of S100A2. The protein concentration was
30 μM, i.e. approximately 1000-fold higher than the apparentKd
for Zn2+ (25±6 nM). Thus, virtually all Zn2+ ions present were
bound by S100A2, which enables the stoichiometry of Zn2+ per
S100A2 to be determined. Upon addition of Zn2+ to S100A2-
WT an increase in UVabsorption between 205 and 240 nm was
observed. UV difference spectra revealed a maximum at 203 nm
(ε=10,000 M−1 cm−1) and shoulders at 208 and 221 nm (Fig.
5). No further spectral changes were observed after addition of
1.3 equivalents of Zn2+ per S100A2-WT subunit, implying
saturation of the binding sites. The observed spectral changes
arise from (sulfur→Zn2+) ligand to metal charge transfer
(LMCT) bands and show that Zn2+ is bound by cysteine
residues. Comparison of the spectra with those from Zn2+-
S100A3 [37] show that the extinction coefficient of Zn2+–
S100A2-WT is about 5 times lower and that the LMCTbands are
not as pronounced as in the case Zn2+–S100A3. S100A3 binds 2
Zn2+ per subunit, coordinated by 7 cysteine residues [37]. The
stoichiometry of 1.3 Zn2+ ions per S100A2 shows that the
protein binds less than 2 Zn2+ ions per subunit, as proposed
previously [6,7]. Furthermore, the lower extinction coefficient
points towards coordination by fewer cysteine residues than in
the case of S100A3. Since Since nitrogen→Zn2+ LMCT bands
overlay partially with those of the CysS→Zn2+ LMCT bands, it
is difficult to obtain a precise number of Cys thiols involved in
coordination. The intensity of the bands accounts for one to two
cysteine ligands for the first Zn2+ bound.
The course of the Zn2+ titration (Fig. 5) is characterized by a
steep slope until a stoichiometry of one equivalent of Zn2+ per
S100A2-WT subunit is reached. The slope decreases slightly asa further 0.3 equivalents Zn2+ are added and saturation is
reached. The data fit well to the results obtained from size
exclusion chromatography and the Zn2+ content of the fractions
containing S100A2 tetramer. The stoichiometry of approxi-
mately 1.3 Zn2+ per subunit can be readily explained by a
stoichiometry of 5 Zn2+ per S100A2 tetramer.
3.6. Zinc ligands and coordination geometry
The analysis of metal-binding sites by site directed
mutagenesis is susceptible to misinterpretation in the case
where mutation of some residues at distant sites have an
unexpected long-range effect on the metal ion affinity [38,39].
Such effect may occur even though the coordination geometry
is not directly affected. It is difficult to recognize such long
range effects from affinity measurements. In order to dis-
criminate between the elimination of a Zn2+-binding site by
mutation and long-range effects, we investigated the structure of
the Zn2+-binding sites in all S100A2 variants with Co2+ as an
intrinsic spectroscopic probe and analyzed changes in metal ion
coordination. Substitution of Zn2+ by Co2+ is a powerful tool,
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as on the geometry of the binding site. Representative UV/Vis,
CD and MCD spectra of Co2+–S100A2-WTand Co2+–S100A2
variants are shown in Figs. 6 and 7. Octahedrally coordinated
Co2+ usually shows weak d–d transitions in the visible region
(ε≈5–10 M−1 cm−1) whereas the molar absorptivity increases
up to 100-fold for tetrahedral coordination sites [40]. These
electronic transitions at 500–800 nm are sensitive to the nature
and number of ligand donor atoms. In the case of thiolate sulfur,
the d–d absorption maxima shift towards lower energy and
intense sulfur→Co2+ LMCT bands around 305–350 nm will
appear.
Upon binding of Co2+ to S100A2-WT and its variants,
distinct UV/Vis absorption maxima around 350 nm as well as
between 500 and 700 nm (Figs. 6, 7) were observed. These
features are absent in mutants where Cys21 was mutated to Ser
(Fig. 7A, E). As a control, Zn2+ was added to Co2+–S100A2.
Displacement of the Co2+ was observed (data not shown),
revealing that Co2+ binds specifically in the Zn2+-binding sites.
The intensity of the d–d transitions in the visible region with an
ε of 300–500 M−1 cm−1 is indicative of tetrahedral metal
coordination. This conclusion is substantiated by the corre-
sponding MCD spectra of Co2+–S100A2-WT showing a strong
MCD band at 665 nm, a shoulder at 606 nm and a weak positive
band at 548 nm. Strikingly, the UV/Vis spectra of Co2+
substituted S100A2–C86S (Fig. 7B) and S100A2–C93S (Fig.
7C) closely resembles the spectrum of Co2+–S100A2-WT (Fig.
6A) with identical maxima and extinction coefficients for the
CysS→Co2+ as well as for the d–d transitions, demonstrating
that no essential ligand was changed, neither in site 1 or in site 2.Fig. 6. Binding of Co2+ to S100A2 in 20 mM Tris–HCl, 5 mM MgCl2, pH 8.3. (A
calculated per S100A2 subunit. (A) UV/Vis difference spectra, (B) CD spectra, (C) M
(D) UV/Vis difference spectra; (E) CD spectra; (F) MCD spectra. Addition of 1.3 equ
bands.Co2+–S100A2–C2S, which lacks Cys2 required for Zn2+
site 2, shows a UV/Vis spectrum (Fig. 6D) similar to S100A2-
WT with the maximum of the d–d transition shifted to 623 nm
(ε≈315 M−1 cm−1). The MCD spectrum is slightly better
resolved but reveals features similar to the spectrum of Co2+–
S100A2-WT with bands at 664 nm, a shoulder 617 nm, and a
weak positive band at 563 nm. The CysS→Co2+ LMCT band
around 350 nm in Co2+–S100A2-C2S is not as well resolved as
in Co2+–S100A2-WT and its intensity is 40% lower demon-
strating fewer CysS→Co2+ bonds. This observation is
consistent with loss of site 2 in the C2S mutant.
The UV/Vis spectrum of Co2+-substituted S100A2–C2S–
C86S–C93S (Fig. 7D) is almost identical to that of Co2+–
S100A2–C2S. The overall intensity of the spectrum is some-
what lower, since fully saturated Co2+–S100A2–C2S–C86S–
C93S was not obtained due to protein precipitation. The optical
data of Co2+–S100A2C2S indicate that the remaining Zn2+ site
1 has tetrahedral geometry with a small distortion, and that this
site only requires Cys21 as sulfur ligand. The position of the d–
d transitions suggests that the three other ligands of Co2+ are
nitrogen atoms, as coordination of Co2+ by one or two oxygen
atoms would result in a shift towards shorter wavelength.
In contrast to the two C2S mutants, mutation of Cys21 results
in the loss of resolved transitions in the d–d transition region of
the UV-/Vis spectra of Co2+–S100A2–C21S (Fig. 7A) and
S100A2–C21S–C86S–C93S (Fig. 7E). This finding is
explained by a distorted pseudo-tetrahedral coordination of
Co2+ in site as shown by the lower extinction coefficient and the
broad absorption envelope in the visible region. However, the
difference spectrum between Co2+–S100A2 WT and Co2+––C) S100A2-WT 540 μM, Co2+ 135–540 μM,. The extinction coefficient is
CD spectra. (D–F) S100A2–C2S 600 μMwith Co2+ in the range 150–600 μM.
ivalents Co2+ to S100A2-WT resulted in an overall increase in the intensity of the
Fig. 7. Binding of Co2+ to S100A2 variants monitored by UV/Vis difference spectra. The buffer contains 20 mM Tris–HCl, 5 mMMgCl2, pH 8.3. (A) S100A2–C21S
280 μM, Co2+ 280–1120 μM; (B) S100A2–C86S 270 μM, Co2+ 135–675 μM; (C) S100A2–C93S 275 μM, Co2+ 275–960 μM; (D) S100A2–C2S–C86S–C93S
260 μM, Co2+ 260–1170 μM; (E) S100A2–C21S–C86S–C93S 330 μM, Co2+ 330–1320 μM; (F) difference spectrum of Co2+–S100A2–WTminus Co2+–S100A2–
C2S. The extinction coefficients are calculated per S100A2 subunit.
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Co2+-loaded site 2, shows well resolved features. These features
were lost in the C21S mutants suggesting that mutation of site 1
influences the structure of site 2. The difference spectrum
exhibits peaks at 305 and 360 nm in the UV region. The band
centered at 360 nm (Δε=600 M−1 cm−1 per subunit, 2400 M−1cm−1 per tetramer) derives from additional CysS→Co2+
LMCT transitions in S100A2-WT. In the visible region two
peaks at 660 nm and 720 nm (Δε==80 M−1 cm−1 per subunit,
320 M−1 cm−1 per tetramer) are observed corresponding to d–d
transitions of site 2. A minor not well resolved shoulder is
observed around 750 nm. The difference spectrum in the d–d
Fig. 8. Chemical shift mapping of S100A2-WT and S100A2-C2S Zn2+-binding
sites. (A) Overlay of 15N–1H HSQC spectra of 105 μM U–13C,15N labeled
S100A2-WT in buffer containing 20 mMTris–Cl, 90%H2O/10%D2O at pH 8.0
in the absence of Zn2+ ions (black contour lines) and with 0.9 equivalents of Zn2+
(red contour lines). Mapping of the Zn2+-binding site based on chemical shift
changes or intensity was complicated by the absence of assignments for apo-
S100A2. Owing to differences in pH and buffer conditions, we were able to
assign some but not all the resonances to specific residues based on previously
published data [6]. (B) Homology model of apo-S100A2 color coded with
assigned residues that showed a change in the weighted average of amide proton
and nitrogen chemical shifts greater than 0.04 ppm (labeled in (A). All the NMR
data were acquired on a 600 MHz Bruker AVANCE spectrometer at 27 °C. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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lothioneins [41–43], which coordinate Co2+ with four Cys in a
tetrahedral geometry and suggests that the Co2+ is coordinated
mainly by cysteine residues.
The filling of Zn2+-binding sites by Co2+ was followed to
saturation, and the dissociation constants for Co2+ were
calculated from a hyperbolic fit (Table 1). The values for the
dissociation constants of the various Co2+–S100A2 complexes
correlate well with those determined for their corresponding
Zn2+–S100A2 counterparts. Although Co2+-complexes have
stability constants similar to those of Zn2+ complexes in the
presence of oxygen donor atoms, differences in stability
constants between Co2+ and Zn2+ complexes become pro-
nounced for polarizable donor atoms such as nitrogen and sulfur
[44]. The difference in affinity between Co2+ and Zn2+ has also
been attributed to a loss in ligand field stabilization energy of
the d7 Co2+ ion as it changes from an octahedral hexa-aquo ion
to a tetrahedral complex in the protein [45]. As expected the
affinities for Co2+ are about 1000-fold lower, i.e. in the μM vs.
nM range for Zn2+ (Table 1). The presence of high-spin Co(II)
in a tetrahedral metal coordination was further supported by
EPR spectroscopy which is not in contradiction with this
coordination type (see Supplementary data).
3.7. Mapping of zinc induced structural changes by NMR
spectroscopy
NMR spectroscopy was used to characterize the structural
changes induced by the binding of Zn2+ to the wild-type
protein. Addition of 0.9 molar equivalents of Zn2+ to the wild-
type apo-S100A2 protein results in small chemical shift changes
in the 15N-1H NMR spectrum. These perturbations were
mapped to residues in the vicinity of the proposed Zn2+-
binding site 1 (Figs. 8, 9A, C). The absence of significant
changes in the chemical shifts suggests there are only very
limited conformational adjustments required for Zn2+ binding
to the apo-protein. Addition of Zn2+ beyond one stoichiometric
equivalent per subunit results in an increasing degree of
broadening of the NMR signals and a significant loss in signal
intensity. The latter observation is consistent with the
formation of a higher molecular mass species, such as the
tetramer observed by SEC and dynamic light scattering
experiments.
3.8. 3D model of S100A2 and the metal binding sites
In order to characterize the structure of the binding sites,
homology models of apo and Ca2+-loaded S100A2 were
constructed using the crystal structures of apo-S100A3 (pdb
code 1KSO) [32], apo-S100A6 (pdb code 1K9P) and Ca2+-
loaded S100A6 (pdb code 1K96) [33] as templates. S100A2,
S100A3 and S100A6 are closely related as indicated by
sequence identities of 43% and 44%, respectively. The close
relationship between S100A3 and S100A6 is documented by
alignments of their 3D structures. The r.m.s.d of 1.03 Å over
164 Cα positions for the structures of the Ca2+-free dimers
reflects the great similarity of their tertiary structures. In view ofthe high level of sequence identity, it is reasonable to assume
that S100A2 adopts the same tertiary structure as S100A3 and
S100A6. The model of S100A2 comprises residues 1 to 94 but
lacks the three C-terminal residues because the C-terminus of
S100A3 was not resolved in the crystal structure and could not
serve as a template. Both S100A6 and S100A3 bind Zn2+. Each
S100A6 subunit binds one Zn2+ at the N-terminus with Cys3 as
one ligand (Kd=100 nM) [46], whereas S100A3 binds 2 Zn
2+
per subunit with high affinity (apparent Kd=4 nM) [32]. The
Zn2+ ions coordinate preferentially to thiolate sulfur (SCys) and
imidazolyl nitrogen (NHis) as deduced from spectroscopic
analyses [37].
A major question was whether the homology model would
fit the spectroscopic data and whether it could be used to
identify Zn2+ coordinating residues other than Cys21 and Cys2.
Three out of four cysteine residues in the S100A2 model are
Fig. 9. Model of the three-dimensional structure of S100A2 and Zn2+ binding
sites. (A) Zn2+-binding site 1 at the homodimer interface. The two S100A2
subunits are shown in blue and red, and the Zn2+ ion in green. (B) Zn2+-binding
site 2 forming the S100A2 tetramer with the Zn2+ ion in green. (C) Putative
structure of Zn2+-binding site 1 including Gln22 in the coordination sphere; the
fourth ligand is possibly a solvent molecule.
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Cys93 (54%) (Fig. 9A). In contrast, the thiol group of Cys86
points inward towards the core and is surrounded by
hydrophobic residues well shielded from the solvent (8%
solvent accessibility). His17 resides one turn below Cys21 on
helix I and the imidazole group is in the model close enough to
the thiol of Cys21 so that they can coordinate the metal ion. The
sidechain of His39 points to the solvent and the long distance
from any other putative Zn2+ coordinating residue makes it is
unlikely that His39 participates in Zn2+ binding. The involve-
ment of the two C-terminal cysteine residues Cys86 and Cys93in Zn2+ binding was proposed by previous studies [6–8].
However, the spectroscopic data of Co2+ substituted S100A2
and variants (Figs. 6, 7) rule out that Cys86 or Cys93 are ligands
for Zn2+. This is in agreement with the homology model where
the sidechain of Cys86 is buried and Cys93 is located in the very
C-terminus. Moving Cys93 into a Zn2+ coordinating position in
site 1 would disrupt an array of conserved phenylalanine
residues (Phe27′, Phe89, Phe90) which would be energetically
quite unfavorable. In contrast Gln22 can coordinate Zn2+ in site
1 via its Nε nitrogen (Fig. 9C). A similar coordination of Zn2+
by a sidechain carboxamide has been observed in the crystal
structure of a mutant of carboanhydrase II [47]. The spectra of
Co2+–S100A2 indicate that there is one sulfur and 3 nitrogen
ligands in site 1. Such coordination is in agreement with
coordination of Zn2+ by His17 and Gln22. However, there is no
further residue in the proximity of Zn2+-binding site 1 that could
provide the putative third nitrogen for coordination. Never-
theless the site is located at the surface of the protein and the
empty coordination site is solvent exposed (Fig. 9A C).
Therefore the third nitrogen ligand detected in the Co2+
titrations might have been provided by a Tris molecule present
in the buffer. Such a coordination by Tris has also been observed
in a crystal structure of a mutant of carboanhydrase II [47]. In
the absence of Tris a water molecule might serve as ligand.
Using size exclusion chromatography and dynamic light
scattering, we showed that binding of Zn2+ to site 2 triggers the
formation of a S100A2 tetramer. The spectroscopic data
indicate that in the tetramer, one Zn2+ is coordinated by 4
cysteine residues, i.e. most likely each subunit provides Cys2 as
ligand for the bridging Zn2+ (Fig. 9B). The model of apo-
S100A2 reveals that the Cys2 residues from both subunits in the
dimer have a distance of approximately 20 Å. This distance can
decrease to 10 Å through a slight unwinding of helix I by only
one residue combined with a movement of Ser3 and Ser4. Both
serine residues following Cys2 are not involved in the dimer
interface and do not form any sidechain hydrogen bonds in the
model. Thus, it is conceivable that reorganization in the vicinity
of the N-terminus could occur at low energy costs, which would
be compensated by the contributions from binding of the Zn2+
ion. Such a scenario is supported by with the CD spectroscopic
data, which show that Zn2+ binding to site 2 causes a slight
decrease in α-helical content (Fig. 2).
4. Discussion
Our studies suggest that Zn2+ acts as a potent regulatory
element for the nuclear EF-hand protein S100A2. Zn2+ binds to
S100A2 with high affinity (apparent Kd 25±6 nM) and
modulates the tertiary and quaternary structure as well as its
affinity for Ca2+. The availability of stable and well character-
ized Cys→Ser variants of S100A2 was essential, enabling
assignment of the ligands within each of the Zn2+-binding sites
by various biophysical methods. We identified two Cys residues
important for coordinating Zn2+, Cys21 in site 1 and Cys2 in
site 2.
Site 1 is located close to the dimer interface at the surface of
S100A2. It is composed of the thiolate sulfur from Cys21 and
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The optical and magnetic studies with Co2+ to probe site 1
reveal tetrahedral coordination, presumably with two further
nitrogen ligands provided by Gln22 of the same subunit and a
Tris molecule which could be replaced by another solvent
molecule. Tetrahedral coordination of Zn2+, as shown in our
study by the Co2+ substitution experiments, was also observed
in the structures of Zn2+-loaded S100A7, S100A12 (Cu2+ in the
Zn2+-binding site) and S100B [48–50]. These three S100
proteins contain a common Zn2+-binding motif: three out of
four residues involved in metal ion coordination are conserved
with regard to position and residue type: a His (S100A7,
S100A12, S100B) and an Asp (S100A7, S100A12) or His
(S100B) are located on the first subunit; a further His is
contributed by the second subunit; the fourth ligand is a His or
Glu from the second subunit. Interestingly, the first His of this
well-conserved motif corresponds to His17 in S100A2.
However, the Asp of this binding motif is replaced by a Phe
in S100A2, which cannot coordinate Zn2+. Cys21 compensates
the missing Asp in S100A2 and thereby creates Zn2+-binding
site 1 which is different from other known S100 protein
structures.
It is highly likely that Zn2+-binding site 2 in S100A2 is
formed by the association of two S100A2 homodimers, such
that coordination of one Zn2+ ion is coordinated by the four
Cys2 residues in a tetrahedral geometry [Zn(Cys2)4]. Each
dimer provides two Cys to coordinate the Zn2+, triggering the
formation of the observed tetramer. In an alternative model each
S100A2 dimer might provide only one Cys2 residue which
would result in a mixed coordination by sulfur, nitrogen/
oxygen, however the data presented here are in better agreement
with coordination by 4 Cys sulfurs. Furthermore the results
from bis-ANS fluorescence experiments suggest that Zn2+
binding to site 2 induces the exposure of hydrophobic residues
which might stabilize the protein–protein interaction. A similar
dimerization of two entities triggered by a metal-ion bridging
both proteins was observed in the structures of Zn2+-bridged
Rad50 [51] and the Cu+ linked ATX1–Ccc2 complex [52]. The
driving forces for the protein complex formation were metal ion
binding as we observe here for S100A2.
NMR data provides additional insight into the local envi-
ronmental of the Zn2+-binding site 1. The site is most likely
preformed in the apo and Ca2+-loaded states of S100A2 as
indicated by the Ca2+-binding and modeling data. Hence,
introducing Zn2+ at this site has a minor effect on the overall
secondary and tertiary structure of the protein as reported by
NMR and other biophysical measurements. In contrast,
structural changes were triggered by Zn2+ binding at site 2 as
shown by CD spectroscopy.
Zn2+ is highly abundant in the cell where it is tightly bound
to glutathione and Zn2+-binding proteins. Consequently the
concentration of free Zn2+ in a resting cell is assumed to be in
the pM to low nM range. However, the intracellular Zn2+
concentration is not constant and rapid changes in free Zn2+ are
observed in different cell types. Excitation of neuronal cells
results in a fast and transient increase in intracellular Zn2+ of at
least 40 nM [53]. In particular nuclear Zn2+ release wasobserved in injured neurons [54] and in endothelial cells upon
activation of inducible NO synthase [55]. At such elevated
concentrations, Zn2+ will bind to human S100A2 interrupting
nuclear Ca2+ signaling pathways. Remarkably, the orthologous
proteins from cow and dog lack the Cys2 and Cys21 residues,
required for Zn2+ binding. This strongly implies that S100A2 in
these organisms will not bind Zn2+ and suggests that the
regulation of S100A2 by Zn2+ is specific for primates. The role
of Zn2+ as a regulatory ion has been shown for intracellular
signaling proteins, including protein tyrosine phosphatases
[56] or caspases [57]. S100B [23,36,50] and S100A12 [58]
have an affinity in the nM range for Zn2+ like S100A2. How-
ever, Zn2+ binding to S100B and S100A12 increases the Ca2+-
affinity (S100B ca. 3-fold; S100A12 ca. 1500 fold), whereas
Zn2+ binding to S100A2 decreases its Ca2+ affinity (ca. 300-
fold), underlining the role of Zn2+ binding as a regulatory
element.
In contrast to the transient elevated concentrations of free
intracellular Zn2+ noted above, prolonged increased Zn2+
concentrations are observed under oxidative stress conditions.
Zn2+ is released from zinc-proteins, metallothioneins, or zinc-
glutathione complexes by oxidation of the coordinating thiol
groups [59,60]. Nevertheless, the Zn2+-binding sites of
S100A2, which also involve cysteines as ligands, might stay
intact at conditions of low oxidative stress due to the nuclear
localization of S100A2. In the nucleus the levels of reduced
glutathione are three-fold higher than in the cytoplasm [61]
which protect nuclear S100A2 from oxidation. Such was
observed in a previous study where oxidation of S100A2 in the
nucleus did not occur when cells were incubated with hydrogen
peroxide concentrations below 1 mM [62], whereas intracellular
metallothionein oxidation and subsequent Zn2+ release is
observed already at 200 μM hydrogen peroxide [63]. We
propose that the availability of free Zn2+ under conditions of
oxidative stress may inhibit S100A2 mediated Ca2+ signaling,
like e.g. p53 activation. Oxidative stress is a significant driving
force in carcinogenesis [64] and Zn2+ released by extended low
level oxidative stress might contribute to the carcinogenity by
reducing the activation of p53 through S100A2. Further studies
to characterize the influence of Zn2+ on the S100A2–p53
interaction are under way.
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